Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 33

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis

Ryan, Amy B., Zeitlin, Scott O., Scrable, Heidi·2006·Neurobiology of Disease
DOI 10.1016/j.nbd.2006.08.002
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2006.08.002

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 38

  1. Albin, 1991, Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study, Ann. Neurol., 30, 542, 10.1002/ana.410300406 · DOI
  2. Amson, 2000, Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice, Proc. Natl. Acad. Sci. U. S. A., 97, 5346, 10.1073/pnas.97.10.5346 · DOI
  3. Bae, 2005, p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease, Neuron, 47, 29, 10.1016/j.neuron.2005.06.005 · DOI · Paper page
  4. Bodner, 2006, From the cover: pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases, Proc. Natl. Acad. Sci. U. S. A., 103, 4246, 10.1073/pnas.0511256103 · DOI · Paper page
  5. Cha, 2000, Transcriptional dysregulation in Huntington's disease, Trends Neurosci., 23, 387, 10.1016/S0166-2236(00)01609-X · DOI · Paper page
  6. Cronin, 2001, The lac operator-repressor system is functional in the mouse, Genes Dev., 15, 1506, 10.1101/gad.892001 · DOI
  7. DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
  8. Dragatsis, 2000, Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice, Nat. Genet., 26, 300, 10.1038/81593 · DOI · Paper page
  9. Duyao, 1995, Inactivation of the mouse Huntington's disease gene homolog Hdh, Science, 269, 407, 10.1126/science.7618107 · DOI · Paper page
  10. Feng, 2006, p53 tumor suppressor protein regulates the levels of huntingtin gene expression, Oncogene, 25, 1, 10.1038/sj.onc.1209021 · DOI
  11. Fusco, 1999, Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease, J. Neurosci., 19, 1189, 10.1523/JNEUROSCI.19-04-01189.1999 · DOI · Paper page
  12. Gomez-Lazaro, 2004, p53: twenty five years understanding the mechanism of genome protection, J. Physiol. Biochem., 60, 287, 10.1007/BF03167075 · DOI
  13. Hackam, 1999, In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease, Hum. Mol. Genet., 8, 25, 10.1093/hmg/8.1.25 · DOI
  14. Hickey, 2003, Apoptosis in Huntington's disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 27, 255, 10.1016/S0278-5846(03)00021-6 · DOI · Paper page
  15. Ho, 2001, The molecular biology of Huntington's disease, Psychol. Med., 31, 3, 10.1017/S0033291799002871 · DOI
  16. Kotliarova, 2005, Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates, J. Neurochem., 93, 641, 10.1111/j.1471-4159.2005.03035.x · DOI
  17. Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  18. Li, 1999, Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin, J. Neurosci., 19, 5159, 10.1523/JNEUROSCI.19-13-05159.1999 · DOI
  19. Luthi-Carter, 2000, Decreased expression of striatal signaling genes in a mouse model of Huntington's disease, Hum. Mol. Genet., 9, 1259, 10.1093/hmg/9.9.1259 · DOI · Paper page
  20. Luthi-Carter, 2002, Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain, Hum. Mol. Genet., 11, 1911, 10.1093/hmg/11.17.1911 · DOI · Paper page
  21. Maier, 2004, Modulation of mammalian life span by the short isoform of p53, Genes Dev., 18, 306, 10.1101/gad.1162404 · DOI · Paper page
  22. Meade, 2002, Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice, J. Comp. Neurol., 449, 241, 10.1002/cne.10295 · DOI
  23. Menalled, 2005, Knock-in mouse models of Huntington's disease, NeuroRx, 2, 465, 10.1602/neurorx.2.3.465 · DOI
  24. Menalled, 2000, Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease, Exp. Neurol., 162, 328, 10.1006/exnr.1999.7327 · DOI
  25. Menalled, 2003, Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats, J. Comp. Neurol., 465, 11, 10.1002/cne.10776 · DOI · Paper page
  26. Nasir, 1995, Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell, 81, 811, 10.1016/0092-8674(95)90542-1 · DOI · Paper page
  27. Ryan, 2004, Visualization of the dynamics of gene expression in the living mouse, Mol. Imaging, 3, 33, 10.1162/153535004773861705 · doi:10.1162/153535004773861705
  28. Saudou, 1998, Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95, 55, 10.1016/S0092-8674(00)81782-1 · DOI · Paper page
  29. Shahbazian, 2001, Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion, Neurobiol. Dis., 8, 974, 10.1006/nbdi.2001.0444 · DOI
  30. Sharp, 1995, Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, 14, 1065, 10.1016/0896-6273(95)90345-3 · DOI · Paper page
  31. Sieradzan, 2001, The selective vulnerability of nerve cells in Huntington's disease, Neuropathol. Appl. Neurobiol., 27, 1, 10.1046/j.0305-1846.2001.00299.x · DOI · Paper page
  32. Slow, 2005, Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions, Proc. Natl. Acad. Sci. U. S. A., 102, 11402, 10.1073/pnas.0503634102 · DOI · Paper page
  33. Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
  34. Young, 2002, A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy, J. Biol. Chem., 277, 2852, 10.1074/jbc.M108769200 · DOI
  35. Zeitlin, 1995, Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue, Nat. Genet., 11, 155, 10.1038/ng1095-155 · DOI · Paper page
  36. Zhang, 2003, Depletion of wild-type huntingtin in mouse models of neurologic diseases, J. Neurochem., 87, 101, 10.1046/j.1471-4159.2003.01980.x · DOI
  37. Zhao, 2004, PromoLign: a database for upstream region analysis and SNPs, Human Mutat., 23, 534, 10.1002/humu.20049 · DOI
  38. Zucker, 2005, Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1, Hum. Mol. Genet., 14, 179, 10.1093/hmg/ddi014 · DOI

Cited by

See all 33

Metadata

Authors
Ryan, A. B., Zeitlin, S. O., & Scrable, H.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2006-11
Volume
24
Issue
2
Pages
419-427
ISSN
0969-9961
DOI
10.1016/j.nbd.2006.08.002
Cited by
33
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis. https://app.cochat.ai/papers/10.1016/j.nbd.2006.08.002
The paper
Ryan, A. B., Zeitlin, S. O., & Scrable, H. (2006). Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2006.08.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.